Obesity increases the risk of hepatic fibrosis in young adults with type 2 diabetes mellitus: the need to screen
Authors:
- 24 September 2024
- Vol. 32 (10) , 1967-1974
Abstract
Objective: The objective of this study was to determine the prevalence of metabolic dysfunction‐associated steatotic liver disease (MASLD) in young compared with older adults.Methods: Individuals (n = 1420) with (63%) and without type 2 diabetes mellitus (T2D; 37%) who attended internal medicine clinics and did not have a known history of MASLD underwent laboratory evaluation and transient elastography to assess for hepatic steatosis and fibrosis. Magnetic resonance elastography and liver biopsy were recommended when indicated.Results: A total of 243 participants were ages p < 0.01). In young adults, T2D and obesity were the strongest risk factors for hepatic fibrosis (odds ratios 4.33 [95% CI: 1.37–13.68] and 1.16 [95% CI: 1.07–1.25], respectively; p < 0.05).Conclusions: There is a high prevalence of clinically significant hepatic fibrosis in young adults with cardiometabolic risk factors. Up to one in seven young adults with obesity and T2D had clinically significant hepatic fibrosis on elastography. This highlights the need to screen young adults with cardiometabolic risk factors for MASLD for early detection and intervention.Keywords
Funding Information
- National Institutes of Health (DK‐120331)
- Echosens
This publication has 44 references indexed in Scilit:
- Cardiovascular Risk Factor Prevalence, Treatment, and Control in US Adults Aged 20 to 44 Years, 2009 to March 2020JAMA, 2023
- Global burden of NAFLD and chronic liver disease among adolescents and young adultsHepatology, 2021
- Type 2 diabetes mellitus increases the risk of hepatic fibrosis in individuals with obesity and nonalcoholic fatty liver diseaseObesity, 2021
- Trends in Prevalence of Diabetes and Control of Risk Factors in Diabetes Among US Adults, 1999-2018JAMA, 2021
- Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 DiabetesClinical Gastroenterology and Hepatology, 2018
- Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes RegisterDiabetologia, 2018
- The economic and clinical burden of nonalcoholic fatty liver disease in the United States and EuropeHepatology, 2016
- Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomesHepatology, 2015
- Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver diseaseHepatology, 2011
- Importance of Changes in Adipose Tissue Insulin Resistance to Histological Response During Thiazolidinedione Treatment of Patients with Nonalcoholic Steatohepatitis†Hepatology, 2009